Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Int J Rheum Dis. 2013 Oct;16(5):578-82. doi: 10.1111/1756-185X.12133. Epub 2013 Jun 20.
Up to now there have been no human studies to evaluate the effect of sesame (Sesamum indicum L.) in osteoarthritis patients; this study was designed to assess the effect of administration of sesame on clinical signs and symptoms in patients with knee osteoarthritis (OA).
Fifty patients with knee OA referred to the only specialty and subspecialty orthopedic centers in the north-west of Iran, were selected and divided into two groups, namely control and sesame groups. Twenty-five patients in the control group received standard treatment while 25 patients in the sesame group received 40 g/day sesame by oral administration during 2 months of the study along with standard drug therapy. The KOOS Questionnaire, Timed Up and Go (TUG) and Visual Analog Scale (VAS) tests were used for clinical assessments.
There was significant difference in pain intensity between the two groups (P = 0.004) after treatment. The mean score of the KOOS Questionnaire in both treatment and control groups was significantly increased (P = 0.001 and P = 0.001, respectively) compared with baseline. The mean score of the TUG Questionnaire in both treatment and control groups was significantly decreased (P = 0.001 and P = 0.001, respectively) compared with baseline. There was significant difference in post-treatment scores of the KOOS Questionnaire (P = 0.009) and TUG (P = 0.002) between the two groups.
The present study showed a positive effect of sesame in improving clinical signs and symptoms in patients with knee OA and indicated the fact that sesame might be a viable adjunctive therapy in treating OA.
迄今为止,尚未有研究评估芝麻(Sesamum indicum L.)对骨关节炎患者的影响;本研究旨在评估芝麻对膝骨关节炎(OA)患者临床体征和症状的影响。
从伊朗西北部唯一的专科和亚专科骨科中心选取了 50 例膝骨关节炎患者,并将其分为对照组和芝麻组。对照组 25 例患者接受标准治疗,芝麻组 25 例患者在研究期间每天口服 40g 芝麻,并同时接受标准药物治疗。采用 KOOS 问卷、计时起立行走测试(TUG)和视觉模拟量表(VAS)对临床情况进行评估。
治疗后两组间疼痛强度存在显著差异(P=0.004)。两组的 KOOS 问卷评分均显著升高(P=0.001 和 P=0.001),与基线相比。两组的 TUG 问卷评分均显著降低(P=0.001 和 P=0.001),与基线相比。两组患者 KOOS 问卷(P=0.009)和 TUG(P=0.002)的治疗后评分均存在显著差异。
本研究表明芝麻可改善膝骨关节炎患者的临床体征和症状,表明芝麻可能是治疗 OA 的一种可行的辅助治疗方法。